Market Overview

Evercore ISI Raises 2019 Estimates For Lodging Stocks, Says Environment Favorable For Sector

Share:
Evercore ISI Raises 2019 Estimates For Lodging Stocks, Says Environment Favorable For Sector
Related DRH
Benzinga Pro's 5 Stocks To Watch Today
Benzinga's Top Upgrades, Downgrades For March 29, 2018
Related H
Earnings Scheduled For October 30, 2018
Why Longbow Research Is Bullish On 5 Hotel Stocks
Hyatt Hotels: May Have Short-Term Upside (Seeking Alpha)

Evercore ISI is refining its estimates on lodging companies in the wake of first-quarter earnings reports and raised its 2019 EPS estimates across the board. 

The Analyst

Evercore ISI’s Rich Hightower.

The Ratings

  • DiamondRock Hospitality Company (NYSE: DRH) was downgraded from Outperform to In-Line with a price target lowered from $12.50 to $12. (See Hightower's track record here.)
  • Hyatt Hotels Corporation (NYSE: H)'s price target was raised from $81 to $84. The analyst reiterated an In-Line rating.
  • Hilton Hotels (NYSE: HLT) was upgraded from In-Line to Outperform with a price target lifted from $80 to $86.
  • Host Hotels and Resorts Inc (NYSE: HST) was upgraded from In-Line to Outperform. The analyst raised the price target from $22 to $23.
  • LaSalle Hotel Properties (NYSE: LHO)’s price target was raised from $32 to $34. The analyst reiterated an In-Line rating.
  • Marriott International Inc (NASDAQ: MAR) was upgraded from In-Line to Outperform with a price target raised from $146 to $155.
  • Pebblebrook Hotel Trust (NYSE: PEB) was upgraded from In-Line to Outperform with a price target lowered from $39 to $38. 
  • Park Hotels & Resorts Inc (NYSE: PK) was maintained at Outperform with a $31 price target.
  • Sunstone Hotel Investors Inc (NYSE: SHO) was upgraded from Underperform to In-Line with a  price target lifted from $15.50 to $16.50.

The Thesis

Earnings estimates and the core operating forecast through 2019 were raised for lodging companies in Evercore ISI's coverage universe. 

"We are now in-line with or slightly above consensus estimates for 2018 and 2019 in practically every case," Hightower said. 

Economic growth, rising interest rates and more manageable industry supply pressures are making lodging an investor favorite, the analyst said. 

The biggest risk facing lodging equities — besides an unforeseen economic downturn — is LaSalle Hotel Properties spurning Pebblebrook Hotel Trust’s purchase offer, Hightower said. Pebblebrook raised its bid for LaSalle Hotel Properties last month to $3.6 billion. The analyst is modeling a 50-percent chance LaSalle will accept the offer. 

Related Links: 

Booking Holdings' CEO Isn't Worried About Airbnb

Morgan Stanley Analyzes The Lodging Sector's M&A Potential 

Latest Ratings for DRH

DateFirmActionFromTo
Nov 2018Wells FargoMaintainsMarket PerformMarket Perform
Nov 2018Wells FargoDowngradesOutperformMarket Perform
Aug 2018CitigroupMaintainsNeutralNeutral

View More Analyst Ratings for DRH
View the Latest Analyst Ratings

Posted-In: Analyst Color Upgrades Downgrades Price Target Reiteration Travel Analyst Ratings General Best of Benzinga

 

Related Articles (DRH + H)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
LXFTKeyBancDowngrades0.0
CPAImperial CapitalDowngrades68.0
PRMWImperial CapitalInitiates Coverage On18.0
TGTKeyBancInitiates Coverage On110.0
QCOMMorgan StanleyUpgrades0.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

The IPO Outlook For The Week Of May 20: New Ways To Play China, Pharma, Finance

Uniqure Notches Bullish Initiation On Gene Therapy Prospects